DYADIC INTERNATIONAL INC Interest Income (Expense), Nonoperating, Net
DYADIC INTERNATIONAL INC (DYAI) reported Interest Income (Expense), Nonoperating, Net of $416.69 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2024-03-28
- DYADIC INTERNATIONAL INC interest income (expense), nonoperating, net for the quarter ending 2023-12-31 was $96.90K, a 4.03% increase year-over-year.
- DYADIC INTERNATIONAL INC interest income (expense), nonoperating, net for the quarter ending 2023-09-30 was $105.86K, a 94.96% increase year-over-year.
- DYADIC INTERNATIONAL INC interest income (expense), nonoperating, net for the quarter ending 2023-06-30 was $109.19K, a 263.87% increase year-over-year.
- DYADIC INTERNATIONAL INC interest income (expense), nonoperating, net for the quarter ending 2023-03-31 was $104.73K, a 3428.67% increase year-over-year.
- DYADIC INTERNATIONAL INC interest income (expense), nonoperating, net for fiscal 2023 was $416.69K, a 130.95% increase from fiscal 2022.
- DYADIC INTERNATIONAL INC interest income (expense), nonoperating, net for fiscal 2022 was $180.42K, a 248.95% increase from fiscal 2021.
- DYADIC INTERNATIONAL INC interest income (expense), nonoperating, net for fiscal 2021 was $51.70K, a 88.43% decline from fiscal 2020.
- DYADIC INTERNATIONAL INC interest income (expense), nonoperating, net for fiscal 2020 was $447.00K, a 54.62% decline from fiscal 2019.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 3 month as first filed | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $96.90K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $202.76K derived: sum of 2 quarters · filed 2024-03-28 | $311.95K derived: sum of 3 quarters · filed 2024-03-28 | $416.69K 10-K · filed 2024-03-28 | |
| 2023-09-30 | $105.86K 10-Q · filed 2023-11-08 | $215.06K derived: sum of 2 quarters · filed 2023-11-08 | $319.79K 10-Q · filed 2023-11-08 | $412.93K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-06-30 | $109.19K 10-Q · filed 2023-08-09 | $213.93K 10-Q · filed 2023-08-09 | $307.07K derived: sum of 3 quarters · filed 2024-03-28 | $361.37K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-03-31 | $104.73K 10-Q · filed 2023-05-10 | $197.87K derived: sum of 2 quarters · filed 2024-03-28 | $252.17K derived: sum of 3 quarters · filed 2024-03-28 | $282.18K derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-12-31 | $93.14K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $147.44K derived: sum of 2 quarters · filed 2024-03-28 | $177.45K derived: sum of 3 quarters · filed 2024-03-28 | $180.42K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $54.30K 10-Q · filed 2023-11-08 | $84.31K derived: sum of 2 quarters · filed 2023-11-08 | $87.28K 10-Q · filed 2023-11-08 | $89.21K derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $30.01K 10-Q · filed 2023-08-09 | $32.98K 10-Q · filed 2023-08-09 | $34.91K derived: sum of 3 quarters · filed 2023-08-09 | $38.11K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $2.97K 10-Q · filed 2023-05-10 | $2.97M 10-Q · filed 2022-05-12 | $4.90K derived: sum of 2 quarters · filed 2023-05-10 | $8.10K derived: sum of 3 quarters · filed 2023-05-10 | $29.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $1.93K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $5.13K derived: sum of 2 quarters · filed 2023-03-29 | $26.03K derived: sum of 3 quarters · filed 2023-03-29 | $51.70K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $3.20K 10-Q · filed 2022-11-10 | $24.10K derived: sum of 2 quarters · filed 2022-11-10 | $49.77K 10-Q · filed 2022-11-10 | $25.75M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $20.90K 10-Q · filed 2022-08-10 | $46.57K 10-Q · filed 2022-08-10 | $25.75M derived: sum of 3 quarters · filed 2022-08-10 | $25.82M derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | $25.67M 10-Q · filed 2022-05-12 | $25.67K 10-Q · filed 2021-05-13 | $25.73M derived: sum of 2 quarters · filed 2022-05-12 | $25.80M derived: sum of 3 quarters · filed 2022-05-12 | $25.95M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $55.22K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $132.03K derived: sum of 2 quarters · filed 2022-03-29 | $278.62K derived: sum of 3 quarters · filed 2022-03-29 | $447.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $76.81K 10-Q · filed 2021-11-10 | $223.40K derived: sum of 2 quarters · filed 2021-11-10 | $391.78K 10-Q · filed 2021-11-10 | $599.00K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $146.59K 10-Q · filed 2021-08-12 | $314.97K 10-Q · filed 2021-08-12 | $522.19K derived: sum of 3 quarters · filed 2021-08-12 | $767.22K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $168.38K 10-Q · filed 2021-05-13 | $375.60K derived: sum of 2 quarters · filed 2021-05-13 | $620.63K derived: sum of 3 quarters · filed 2021-05-13 | $886.35K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $207.22K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $452.25K derived: sum of 2 quarters · filed 2021-03-30 | $717.97K derived: sum of 3 quarters · filed 2021-03-30 | $984.93K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $245.03K 10-Q · filed 2020-11-12 | $510.75K derived: sum of 2 quarters · filed 2020-11-12 | $777.71K 10-Q · filed 2020-11-12 | $1.02M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $265.72K 10-Q · filed 2020-08-13 | $532.68K 10-Q · filed 2020-08-13 | $779.53K derived: sum of 3 quarters · filed 2020-08-13 | $1.02M derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | $266.96K 10-Q · filed 2020-05-14 | $513.81K derived: sum of 2 quarters · filed 2020-05-14 | $755.45K derived: sum of 3 quarters · filed 2020-05-14 | $975.04K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $246.85K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $488.49K derived: sum of 2 quarters · filed 2020-03-30 | $708.08K derived: sum of 3 quarters · filed 2020-03-30 | $894.53K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $241.64K 10-Q · filed 2019-11-13 | $461.23K derived: sum of 2 quarters · filed 2019-11-13 | $647.69K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $219.59K 10-Q · filed 2019-08-13 | $406.04K 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | $186.46K 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | $566.15K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |